Genflow Biosciences plc

Direct answer

Genflow Biosciences plc is publicly traded on LSE under the ticker GENF.L.

Genflow Biosciences plc is a biotechnology firm dedicated to devising biological treatments aimed at confronting the impacts of aging. Their goal is to slow down or completely stop the aging process and reduce the frequency of age-related illnesses, thereby extending the period of good health (healthspan). Their primary therapeutic asset is GF-1002, an adeno-associated viral vector-based gene therapy delivered...

Can you invest in Genflow Biosciences plc?

Yes. Genflow Biosciences plc is publicly traded on LSE under the ticker GENF.L.

View deeper analysis

View detailed research on MarketSnap, including financials, valuation tools, and analyst context.

Open research for Genflow Biosciences plc

Detailed equity research is provided by MarketSnap.